These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3345241)

  • 1. Aluminum-related bone disease.
    Malluche HH; Faugere MC
    Blood Purif; 1988; 6(1):1-15. PubMed ID: 3345241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease.
    Felsenfeld AJ; Rodriguez M; Coleman M; Ross D; Llach F
    Kidney Int; 1989 Jun; 35(6):1371-8. PubMed ID: 2770115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone and aluminum].
    Wendling D; Guidet M
    Rev Rhum Mal Osteoartic; 1986 Dec; 53(12):705-13. PubMed ID: 3103201
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteomalacia and bone disease arising from aluminum.
    Coburn JW; Norris KC; Nebeker HG
    Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of fluoride on aluminum-induced bone disease in rats with renal failure.
    Ittel TH; Gruber E; Heinrichs A; Handt S; Hofstädter F; Sieberth HG
    Kidney Int; 1992 May; 41(5):1340-8. PubMed ID: 1614048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE; Johnson CA
    Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aluminium and bone disease in chronic renal failure.
    Malluche HH
    Nephrol Dial Transplant; 2002; 17 Suppl 2():21-4. PubMed ID: 11904354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone histologic response to deferoxamine in aluminum-related bone disease.
    Andress DL; Nebeker HG; Ott SM; Endres DB; Alfrey AC; Slatopolsky EA; Coburn JW; Sherrard DJ
    Kidney Int; 1987 Jun; 31(6):1344-50. PubMed ID: 2441107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum, parathyroid hormone, and osteomalacia.
    Burnatowska-Hledin MA; Kaiser L; Mayor GH
    Spec Top Endocrinol Metab; 1983; 5():201-26. PubMed ID: 6422572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water content of aluminum, dialysis dementia, and osteomalacia.
    Wills MR; Savory J
    Environ Health Perspect; 1985 Nov; 63():141-7. PubMed ID: 3908086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
    Andress DL; Maloney NA; Coburn JW; Endres DB; Sherrard DJ
    J Clin Endocrinol Metab; 1987 Jul; 65(1):11-6. PubMed ID: 3584392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum and chronic renal failure: sources, absorption, transport, and toxicity.
    Wills MR; Savory J
    Crit Rev Clin Lab Sci; 1989; 27(1):59-107. PubMed ID: 2647415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis.
    Smith AJ; Faugère MC; Abreo K; Fanti P; Julian B; Malluche HH
    Am J Nephrol; 1986; 6(4):275-83. PubMed ID: 3777036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical toxic and trophic osseous actions of aluminum: potential explanations.
    Quarles LD
    Miner Electrolyte Metab; 1991; 17(4):233-9. PubMed ID: 1813785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects of aluminum toxicity.
    Hewitt CD; Savory J; Wills MR
    Clin Lab Med; 1990 Jun; 10(2):403-22. PubMed ID: 2197055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved bone formation in dialysis patients after substitution of calcium carbonate for aluminum gels.
    Hercz G; Andress DL; Norris KC; Shinaberger JH; Slatopolsky EA; Sherrard DJ; Coburn JW
    Trans Assoc Am Physicians; 1987; 100():139-46. PubMed ID: 3455064
    [No Abstract]   [Full Text] [Related]  

  • 18. Aluminum and bone: Review of new clinical circumstances associated with Al(3+) deposition in the calcified matrix of bone.
    Chappard D; Bizot P; Mabilleau G; Hubert L
    Morphologie; 2016 Jun; 100(329):95-105. PubMed ID: 26762722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and toxicity of aluminum in renal failure.
    Alfrey AC; Hegg A; Craswell P
    Am J Clin Nutr; 1980 Jul; 33(7):1509-16. PubMed ID: 7395774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.